Silence Therapeutics plc (OTCMKTS:SLNCF – Get Free Report) was up 1.6% during mid-day trading on Wednesday . The company traded as high as $6.10 and last traded at $6.10. Approximately 200 shares changed hands during mid-day trading, a decline of 87% from the average daily volume of 1,595 shares. The stock had previously closed at $6.00.
Silence Therapeutics Stock Performance
The business has a 50 day moving average of $6.19 and a 200-day moving average of $6.94.
Silence Therapeutics Company Profile
Silence Therapeutics plc, a biotechnology company, focuses on the discovery and development novel molecules incorporating short interfering ribonucleic acid (siRNA) to inhibit the expression of specific target genes in hematology, cardiovascular, and rare diseases. The company's mRNAi GalNAc Oligonucleotide Discovery platform consists of precision engineered product candidates designed to target specific disease-associated genes in the liver.
Read More
- Five stocks we like better than Silence Therapeutics
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- Survey Reveals: America’s Most Coveted Businesses in 2024
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- Top 3 Stocks to Play Oil’s Potential Comeback Rally
- What is Forex and How Does it Work?
- Analysts See Growth in CrowdStrike Stock Despite July Setback
Receive News & Ratings for Silence Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Silence Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
